Gilead is requiring 340B covered entities to supply claims data for its branded hepatitis C products to be able to continue to be eligible for bill to / ship to orders for multiple contract pharmacies.
News Alert
Gilead Announces 340B Contract Pharmacy Restrictions that Apply to Hospital and Grantee Entities
Gilead late yesterday imposed conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
